James Xu Selected Research

James Xu Research Topics

2	Acute Coronary Syndrome 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 10/2019
1	Myocardial Infarction 11/2022
1	Infarction (Infarctions) 01/2022
1	ST Elevation Myocardial Infarction 03/2019
1	Ventricular Fibrillation 03/2019
1	Hemorrhage 01/2019
1	Carcinogenesis 06/2017
1	Breast Neoplasms (Breast Cancer) 06/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Heart Failure 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2014
1	Lung Injury 12/2014
1	Drug-Related Side Effects and Adverse Reactions 04/2013
1	Insulin Resistance 04/2013
1	Glucose Intolerance 04/2013

2	Insulin (Novolin)FDA Link 01/2017 - 04/2013
1	Clopidogrel (Plavix)FDA Link 01/2022
1	TicagrelorIBA 01/2022
1	RamucirumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LigandsIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	AntibodiesIBA 10/2019
1	Troponin T (Troponin T1)IBA 03/2019
1	Protein Isoforms (Isoforms)IBA 06/2017
1	Messenger RNA (mRNA)IBA 06/2017
1	ThiazolidinedionesIBA 01/2017
1	PolymersIBA 12/2014
1	carbopol 940 (sodium polyacrylate)IBA 12/2014
1	SolutionsIBA 12/2014
1	Haloperidol (Haldol)FDA LinkGeneric 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Pharmaceutical PreparationsIBA 04/2013
1	Antipsychotic Agents (Antipsychotics)IBA 04/2013
1	Clozapine (Clozaril)FDA LinkGeneric 04/2013
1	Risperidone (Risperdal Consta)FDA LinkGeneric 04/2013

2	Percutaneous Coronary Intervention 11/2022 - 03/2019
2	Therapeutics 01/2020 - 01/2020
1	Tourniquets 01/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Catheters 12/2014
1	Polypharmacy 04/2013